RCP
RCKT icon

Rho Capital Partners’s Rocket Pharmaceuticals RCKT Stock Holding History

Rho Capital Partners’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-656,948
Closed -$4.99M – 4
2017
Q2 		$4.99M Hold
656,948
– – 6.97% 3
2017
Q1 		$5.26M Hold
656,948
– – 7.39% 2
2016
Q4 		$16M Hold
656,948
– – 12.28% 3
2016
Q3 		$24.9M Hold
656,948
– – 16.83% 4
2016
Q2 		$19.6M Hold
656,948
– – 15.64% 3
2016
Q1 		$19.4M Hold
656,948
– – 10.65% 4
2015
Q4 		$29.8M Sell
656,948
-60,698
-8% -$2.65M 10.24% 4
2015
Q3 		$27M Hold
717,646
– – 8.96% 5
2015
Q2 		$14.1M Hold
717,646
– – 4.92% 5
2015
Q1 		$15.6M Buy
+717,646
New +$16.8M 6.49% 5

Other funds holding RCKT

OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return